Dr Agarwal's Eye

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE934C01018
  • NSEID: DRAGARWQ
  • BSEID: 526783
INR
4,983.95
-166.8 (-3.24%)
BSENSE

May 25

BSE+NSE Vol: 1.42 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 18.56% vs 24.38% in Mar 2025

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2026 is 28.27% vs 17.88% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 22.62% vs 30.13% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -11.61% vs 87.45% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Dr Agarwal's Eye With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
470.87
1,482.51
-1,011.64
-68.24%
Other Operating Income
0.00
0.00
0.00
Total Operating income
470.87
1,482.51
-1,011.64
-68.24%
Raw Material Cost
0.00
256.34
-256.34
-100.00%
Purchase of Finished goods
47.73
0.00
47.73
(Increase) / Decrease In Stocks
-0.71
0.00
-0.71
Employee Cost
91.68
287.60
-195.92
-68.12%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
115.88
389.39
-273.51
-70.24%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
70.98
282.26
-211.28
-74.85%
Total Expenditure (Excl Depreciation)
325.56
1,215.59
-890.03
-73.22%
Operating Profit (PBDIT) excl Other Income
145.31
266.92
-121.61
-45.56%
Other Income
5.82
28.75
-22.93
-79.76%
Operating Profit (PBDIT)
151.13
295.67
-144.54
-48.89%
Interest
11.88
6.02
5.86
97.34%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
139.25
289.65
-150.40
-51.92%
Depreciation
45.64
43.63
2.01
4.61%
Profit Before Tax
93.61
246.02
-152.41
-61.95%
Tax
23.51
62.40
-38.89
-62.32%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
70.10
183.62
-113.52
-61.82%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
70.10
183.62
-113.52
-61.82%
Equity Capital
4.83
91.67
-86.84
-94.73%
Face Value
10.00
10.00
0.00
Reserves
341.47
648.70
-307.23
-47.36%
Earnings per share (EPS)
145.13
20.03
125.10
624.56%
Diluted Earnings per share
147.02
20.03
126.99
634.00%
Operating Profit Margin (Excl OI)
30.86%
18.00%
0.00
12.86%
Gross Profit Margin
29.57%
19.54%
0.00
10.03%
PAT Margin
14.89%
12.39%
0.00
2.50%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 470.87 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 18.56% vs 24.38% in Mar 2025

Annual - Standalone Net Profit
Standalone Net Profit 70.10 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 28.27% vs 17.88% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 145.31 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 22.62% vs 30.13% in Mar 2025

Annual - Interest
Interest 11.88 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -11.61% vs 87.45% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.86%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025